medigraphic.com
Instituto Nacional de Salud Pública

2013, Number 4

<< Back Next >>

salud publica mex 2013; 55 (4)

Self-reported early detection activities for breast cancer in Colombia in 2010: impact of socioeconomic and demographic characteristics

Font-Gonzalez A, Piñeros M, de Vries E

Language: English
References: 37
Page: 368-378
PDF size: 206.14 Kb.


ABSTRACT

Objective. To explore which socioeconomic and demographic characteristics influence Colombian women to utilize screening mammography (SMMG). Materials and methods. Data of women aged 40-49 years (n=12 345) and 50-69 years (n=14 771) from the Colombian national survey of demography and health 2010 was analyzed. Risk estimates (odds ratios, OR) of self-reported SMMG use were obtained using logistic regression. Results. Among women aged 50-69 years, high wealth index (OR=4.7; CI95%, 3.9-5.8), affiliation to special or contributory health insurance regime (OR=3.4; CI95% 2.6-4.6 and OR=2.5; CI95% 2.1-3.0 respectively), health consultation in previous year (OR=2.7; CI95% 2.3-3.1), high education level (OR=2.3; CI95% 1.8-2.9) and very good selfreported health (OR=1.5; CI95% 1.1-2.0) positively influenced SMMG utilization. Among women aged 40-49 years, likelihood of having a SMMG was high after a health consultation in the previous year. Conclusions. Socioeconomic and demographic differences in use of SMMG need to be contemplated in screening recommendations before considering an organized population-based programme.


REFERENCES

  1. Registro poblacional de cáncer de Cali. Summary of incidence and mortality. Cali: Universidad del Valle; 2005 [Accessed 11 July 2012]; Available from: http://rpcc.univalle.edu.co/in/SitiosEspecificos/pdf-sitiosespecificos/Sitios_Especificos.php?sitio=9.

  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer indence and mrtality wrldwide: IARC Cancer- Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010 [Accessed 19th/Sep/2011]. Available from: http://globocan.iarc.fr

  3. República de Colombia. Ley 100/1993, de diciembre 23, por la cual se crea el Sistema de Seguridad Social Integral y se dictan otras disposiciones. Bogotá: Ministerio de salud, 1993.

  4. Departamento administrativo nacional de estadística (DANE). Seguridad Social: Trimestre abril - junio 2011. Bogotá: DANE, 2011.

  5. Ministerio de salud de Colombia. Resolución 412 de 2000. Bogotá: Ministerio de salud, 2000.

  6. Ministerio de salud de Colombia. Resolución número 3384 de 2000 (Diciembre 29) Por la cual se modifican parcialmente las resoluciones 412 y 1745 de 2000 y se deroga la resolución 1078 de 2000. Bogotá: Ministerio de salud, 2000.

  7. Anderson B, Shyyan R, Eniu A, Smith R, Yip C, Bese N, et al. Breast cancer in limited-resource countries: An overview of the Breast Health Global Initiative 2005 guidelines. Breast J 2006;12:S3-S15.

  8. Instituto nacional de cancerología (INC). Recomendaciones para la detección temprana de cáncer de mama en Colombia. Bogotá: INC, 2006.

  9. República de Colombia. Acuerdo número 29, Por el cual se define, aclara y actualiza integralmente el plan obligatorio de salud. Bogotá: Ministerio de salud, 2011.

  10. Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JHCL, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-1417.

  11. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-919.

  12. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2010;21:275-282.

  13. McPherson K. Screening for breast cancer—balancing the debate. BMJ 2010;340:c3106.

  14. Harford JB. Breast-cancer early detection in low-income and middleincome countries: do what you can versus one size fits all. Lancet Oncology 2011;12:306-312.

  15. Murillo R, Díaz S, Sánchez O, Perry F, Piñeros M, Poveda C, et al. Pilot implementation of breast cancer early detection programs in Colombia. Breast Care 2008;3:29-32.

  16. Piñeros M, Sánchez R, Cendales R, Perry F, Ocampo R. Patient delay among Colombian women with breast cancer. Salud Publica Mex 2009;51:372-380.

  17. de Charry LC, Carrasquilla G, Roca S. Equidad en la detección del cáncer de seno en Colombia. Rev Salud Publica 2008;10:571-582.

  18. Profamilia and ICF Macro. Colombia: DH, 2010 - Final Report (Spanish) vol 2012. Bogotá: Probienestar de la familia Colombiana (Profamilia) Ministerio de la protección social de Colombia and United States Agency for International Development (USAID), 2011.

  19. Measure Demographic and Health Surveys (DHS). Measure DHS. 2012 [Accessed 11 July 2012]. Available from: http://www.measuredhs.com.

  20. Asociación probienestar de la familia Colombiana (Profamilia). Mapa interactivo de zonas intervenidas. 2011 [Accessed 09 July 2012]. Available from: http://www.profamilia.org.co/encuestaenzonasmarginadas/mapa.html.

  21. Departamento Administrativo Nacional de Estadística (DANE). La visibilidad estadística de los grupos étnicos Colombianos. 2005 [Accessed 15 July 2012]. Available from: http://www.dane.gov.co/files/censo2005/etnia/sys/visibilidad_estadistica_etnicos.pdf.

  22. Aarts M, Voogd A, Duijm L, Coebergh J, Louwman W. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands—associations with stage at diagnosis and survival. Breast Cancer Res Treat 2011;128:517-525.

  23. Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ 2009;338:b2025.

  24. Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004;108:754-760.

  25. Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, et al. The importance of health insurance as a determinant of cancer screening: evidence from the women’s health initiative. Prev Med 2000;31:261-270.

  26. Profamilia and ICF Macro. Colombia: DH, 2005-Final Report (Spanish). Bogotá: Probienestar de la familia colombiana (Profamilia) Ministerio de la proteccion social de Colombia and United Nations Population Fund, 2005.

  27. Soerjomataram I, Pukkala E, Brenner H, Coebergh J. On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat 2008;111:297-302.

  28. Hernández G, Herrán S, Cantor LF. Análisis de las tendencias de mortalidad por cáncer de mama en Colombia y Bogotá, 1981-2000 [Time trends analysis of breast cancer mortality in Colombia and Bogotá, 1981- 2000 ]. Rev Colomb Cancerol 2007;11:32-39.

  29. Piñeros-Petersen M, Pardo-Ramos C, Gamboa-Garay O, Hernández-Suárez G. Atlas de mortalidad por cáncer en Colombia. 3rd ed. Bogotá: INC-IGAC; 2010.

  30. Chamot E, Perneger T. The gynecologist’s role in mammography screening in absence of a public health program. Arch Gynecol Obstet 2003;268:88-93.

  31. Püschel K, Coronado G, Soto G, Gonzalez K, Martinez J, Holte S, et al. Strategies for increasing mammography screening in primary care in Chile: results of a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010;19:2254-2261.

  32. Corbex M, Burton R, Sancho-Garnier H. Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast 2012;21:428-434.

  33. Anderson BO, Cazap E, El Saghir NS, Yip C-H, Khaled HM, Otero IV, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011;12:387-398.

  34. Anderson BO, Yip C-H, Ramsey SD, Bengoa R, Braun S, Fitch M, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J 2006;12:S54-S69.

  35. Piñeros M, Sánchez R, Perry F, García OA, Ocampo R, Cendales R. Demoras en el diagnóstico y tratamiento de mujeres con cáncer de mama en Bogotá, Colombia [Delay for diagnosis and treatment of breast cancer]. Salud Publica Mex 2011;53:478-485.

  36. Yip C-H, Cazap E, Anderson BO, Bright KL, Caleffi M, Cardoso F, et al. Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative. Breast 2011;20, Supplement 2:S12-S9.

  37. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. JNCI 2011;103:1476-1480.




2020     |     www.medigraphic.com